Literature DB >> 984771

In vitro evaluation of the new oral cephalosporin cefatrizine: comparison with other cephalosporins.

C C Blackwell, E H Freimer, G C Tuke.   

Abstract

Cefatrizine (BL-S640), a semisynthetic, orally administered cephalosporin, was found to have an in vitro spectrum of activity comparable to those of four other cephalosporins tested. It is as effective as cephalexin, the other orally administered cephalosporin evaluated, against most species, and it appears to be more effective than cephalexin against many Enterobacter, Haemophilus, and Proteus strains isolated in our hospital. It is not inactivated by the plasmid-determined beta-lactamases of 14 strains of ampicillin-resistant Salmonella typhimurium or the ampicillin resistance determinant of an H. influenza strain from the Center for Disease Control. No synergy was observed between cefatrizine and gentamicin, kanamycin, carbenicillin, or polymyxin when tested against selected strains.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 984771      PMCID: PMC429737          DOI: 10.1128/AAC.10.2.288

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  In vitro evaluation of BL-S640, a new oral cephalosporin antibiotic.

Authors:  G D Overturf; R L Ressler; P B Marengo; J Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

2.  BL-S 640, a cephalosporin with a broad spectrum of antibacterial activity: properties in vitro.

Authors:  F Leitner; R E Buck; M Misiek; T A Pursiano; K E Price
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

3.  Susceptibility of clinical isolates of Enterobacteriaceae to BL-S640, a new oral cephalosporin.

Authors:  C Watanakunakorn; T Bannister; C Glotzbecker
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

4.  Oral and parenteral cephalosporins: the place of cephalexin in antibacterial therapy.

Authors:  M Finland
Journal:  Drugs       Date:  1972       Impact factor: 9.546

5.  Clinical and in vitro evaluation of cephalexin. A new orally administered cephalosporin antibiotic.

Authors:  M E Levison; W D Johnson; T S Thornhill; D Kaye
Journal:  JAMA       Date:  1969-09-01       Impact factor: 56.272

6.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

7.  In vitro activity of cephalosporin antibiotics against Gram-positive bacteria.

Authors:  F H Kayser
Journal:  Postgrad Med J       Date:  1971-02       Impact factor: 2.401

8.  In vitro evaluation of a new oral cephalosporin, cefatrizine (BL-s640).

Authors:  G A Stilwell; H G Adams; M Turck
Journal:  Antimicrob Agents Chemother       Date:  1975-12       Impact factor: 5.191

  8 in total
  3 in total

1.  In vitro activities of five oral cephalosporins against aerobic pathogenic bacteria.

Authors:  S Shadomy; G Wagner; M Carver
Journal:  Antimicrob Agents Chemother       Date:  1977-11       Impact factor: 5.191

2.  Cefatrizine activity compared with that of other cephalosporins.

Authors:  H C Neu; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

3.  Copper-Catalyzed Azide-Alkyne Cycloaddition of Hydrazoic Acid Formed In Situ from Sodium Azide Affords 4-Monosubstituted-1,2,3-Triazoles.

Authors:  Dominik Jankovič; Miha Virant; Martin Gazvoda
Journal:  J Org Chem       Date:  2022-02-11       Impact factor: 4.354

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.